High-sensitivity C-reactive protein level is a significant risk factor for silent cerebral infarction in patients on hemodialysis

Metabolism: Clinical and Experimental

Volumn 57, Issue 1, 2008, Pages 66-70

  Anan, Futoshi ^a   Shimomura, Tsuyoshi ^a   Kaku, Tadayuki ^a   Kaneda, Koji ^a   Imagawa, Masaharu ^a   Tsukagawa, Hiroshi ^b   Masaki, Takayuki ^c   Nawata, Tomoko ^c   Yonemochi, Hidetoshi ^c   Eshima, Nobuoki ^c   Saikawa, Tetsunori ^c   Yoshimatsu, Hironobu ^c  

^a OITA RED CROSS HOSPITAL   (Japan)

^b Department of Internal Medicine   (Japan)

^c OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; URIC ACID;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BODY MASS; BRAIN INFARCTION; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE MARKER; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; INFLAMMATION; JAPAN; KIDNEY DYSFUNCTION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

AGED; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; BODY MASS INDEX; BRAIN; C-REACTIVE PROTEIN; CEREBRAL INFARCTION; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RENAL DIALYSIS; RISK FACTORS;

EID: 36849012095     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.08.007     Document Type: Article

References (31)

1. Seliger S.L., Gillen D.L., Longstreth Jr. W.T., et al. Elevated risk of stroke among patients with end-stage renal disease. Kidney Int 64 (2003) 603-609
2. Iseki K., Kinjyo K., Kimura Y., et al. Evidence for high risk of cerebral hemorrhage in chronic dialysis patients. Kidney Int 44 (1993) 1086-1090
3. Iseki K., and Fukuyama K. Predictors of stroke in patients receiving chronic hemodialysis. Kidney Int 50 (1996) 1672-1675
4. Nakatani T., Naganuma T., Uchida J., et al. Silent cerebral infarction in hemodialysis patients. Am J Nephrol 23 (2003) 86-90
5. Naganuma T., Uchida J., Tsuchida K., et al. Silent cerebral infarction predicts vascular events in hemodialysis patients. Kidney Int 67 (2005) 2434-2439
6. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
7. Ridker P.M. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 336 (2001) 973-979
8. Cesari M., Penninx B.W., Newman A.B., et al. Inflammatory markers and onset of cardiovascular events: results from the health ABC study. Circulation 108 (2003) 2317-2322
9. Hoshi T., Kitagawa K., Yamagami H., et al. Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infraction. Stroke 36 (2005) 768-772
10. Kobayashi S., Okada K., Koide H., et al. Subcortical silent cerebral infarction as a risk factor for clinical stroke. Stroke 28 (1997) 1932-1939
11. Fisher C.M. Lacunar strokes and infarcts. Neurology 32 (1982) 871-876
12. Liao D., Sloan R.P., Cascio W.E., et al. Multiple metabolic syndrome is associated with lower rate variability. Diabetes Care 21 (1998) 2116-2122
13. Rifai N., Tracy R.P., and Ridker P.M. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 45 (1999) 2136-2141
14. Pearson T.A., Mensah G.A., Alexander R.W., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
15. Kohara K., Fujisawa M., Ando F., et al. MTHFR gene polymorphism as a risk factor for silent brain infracts and white matter lesions in the Japanese general population. The NILS-LSA study. Stroke 34 (2003) 1130-1135
16. Braffman B.H., Zimmerman R.A., Trojanowski J.Q., et al. Pathologic correlation with gross and histopathology, 1: lacunar infarction and Virchow Robin spaces. AJR Am J Roentgenol 151 (1988) 551-558
17. Wang A.Y., Woo J., Lam C.W., et al. Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients?. J Am Soc Nephrol 14 (2003) 1871-1879
18. Fassbender K., Bertsch T., Mielke O., et al. Adhesion molecules in cerebrovascular disease. Evidence for an inflammatory endothelial activation in cerebral large-and small-vessel disease. Stroke 30 (1999) 1647-1650
19. Hassan A., Hunt B.J., O'Sullivan M., et al. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain 126 (2003) 424-432
20. Vinters H.V., Ellis W.G., Zarow C., et al. Neuropathologic substrates of ischemic vascular dementia. J Neuropathol Exp Neurol 59 (2000) 931-945
21. Clapp B.R., Hirschfield G.M., Storry C., et al. Inflammation and endothelial function: direct vascular effects of human C-reactive protein on nitric oxide bioavailability. Circulation 111 (2005) 1530-1536
22. Howard G., Wagenknecht L.E., Cai J., et al. Cigarette smoking and other risk factors for silent cerebral infraction in the general population. Stroke 29 (1998) 913-917
23. Bartecci C.E., Mackenzie T.D., and Schrier R.W. The human costs of tobacco use. N Engl J Med 330 (1994) 907-912
24. Frohlich M., Sund M., Lowel H., et al. Independent association of various smoking characteristics with markers of systemic inflammation in men. Results from a representative sample of the general population (MONICA Ausburg Survey 1994/95). Eur Heart J 24 (2003) 1365-1372
25. Ohsawa M., Okayama A., Nakamura M., et al. CRP levels are elevated in smokers but unrelated to the number of cigarettes and are decreased by long-term smoking cessation in male smokers. Prev Med 41 (2005) 651-656
26. Tappia P.S., Troughton K.L., Langley-Evans S.C., et al. Cigarette smoking influences cytokines production and antioxidant defences. Clin Sci 88 (1995) 485-489
27. Francus T., Romano P.M., Manzo G., et al. IL-1, IL-6, and PDGF mRNA expression in alveolar cells following stimulation with a tobacco-derived antigen. Cell Immunol 145 (1993) 156-174
28. Cryer P.E., Haymond M.W., Santiago J.V., et al. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med 295 (1976) 573-577
29. Elenkov I.J., and Chrousos G.P. Stress hormones, proinflammatory and anti-inflammatory cytokines, and autoimmunity. Ann NY Acad Sci 966 (2002) 290-303
30. Zhang L., Kao W.H., Berthier-Schaad Y., et al. C-reactive protein haplotype predicts serum C-reactive protein levels but not cardiovascular disease risk in a dialysis cohort. Am J Kidney Dis 49 (2007) 118-126
31. Arici M., and Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link?. Kidney Int 59 (2001) 407-414